Retrospective analysis of the effectiveness of key Vertidisan®-DiGA exercises for the treatment of vestibulopathy

Retrospective analysis of the effectiveness of key Vertidisan®-DiGA exercises for the treatment of vestibulopathy - VH-16

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028084

Enrollment

250

Registered

2023-09-25

Start date

2021-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H81.3

Interventions

Group 1: Vestibular vertigo are treated by ABEV exercises

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Vestibulopathy

Exclusion criteria

Exclusion criteria: Serious neurological, psychiatric, orthopedic, internal medicine, or ophthalmologic conditions.

Design outcomes

Primary

Measure	Time frame
VSS-sf1-VER questionaire at T0 and T1 (3-4 months after T0)	—

Countries

Germany

Contacts

Public ContactMarkus Wirth

Universitäts-HNO-Klinik Rechts der Isar, TUM, München

markus.wirth@mri.tum.de089 41400

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026